Literature DB >> 15310758

Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms.

Zhaoxia Qu1, Guoliang Qing, Arnold Rabson, Gutian Xiao.   

Abstract

Processing of the nf-kappab2 gene product p100 to generate p52 is a tightly regulated event, consistent with the fact that the processing product, p52, is hardly detected in most cell types, including T cells, although the precursor p100 is expressed abundantly in these cells. However, in T cells transformed by the human T-cell leukemia virus type I (HTLV-I), p100 processing is very active, resulting in high level expression of p52. Because overproduction of p52 is associated with lymphoid hyperplasia and transformation, deregulation of p100 processing may be part of the oncogenic mechanism of HTLV-I. We demonstrated previously that HTLV-I Tax oncoprotein is a potent inducer of p100 processing through specific targeting of IKKalpha via IKKgamma to p100 to trigger p100 phosphorylation and ubiquitination. In this study, we further show that Tax-mediated recruitment of IKKalpha to p100 requires serines 866 and 870 of p100, shown to be essential for inducible processing of p100. Upon interaction with p100, activated IKKalpha phosphorylates both N- and C-terminal serines of p100 (serines 99, 108, 115, 123 and 872), serving as a critical step in Tax-induced p100 processing. Using a genetic approach, we find that beta-transducin repeat-containing protein, a component of the SCF ubiquitin ligase complex, previously shown to be required for physiological p100 processing mediated by nuclear factor-kappaB-inducing kinase, is only partially involved in Tax-induced processing of p100. These results indicate that both beta-transducin repeat-containing protein-dependent and -independent mechanisms contribute to Tax-deregulated p100 processing, further suggesting the involvement of different mechanisms in cellular and viral pathways of p100 processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15310758     DOI: 10.1074/jbc.M403689200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

Authors:  Guoliang Qing; Zhaoxia Qu; Gutian Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-15       Impact factor: 11.205

Review 2.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

3.  Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.

Authors:  Fan Sun; Yadong Xiao; Zhaoxia Qu
Journal:  J Biol Chem       Date:  2015-02-13       Impact factor: 5.157

4.  Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.

Authors:  Zhaoxia Qu; Jing Fu; Pengrong Yan; Jing Hu; Shi-Yuan Cheng; Gutian Xiao
Journal:  J Biol Chem       Date:  2010-02-25       Impact factor: 5.157

5.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

6.  Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.

Authors:  J Fu; P Yan; S Li; Z Qu; G Xiao
Journal:  Oncogene       Date:  2010-09-13       Impact factor: 9.867

7.  Balance between NF-κB p100 and p52 regulates T cell costimulation dependence.

Authors:  Maria Letizia Giardino Torchia; Dietrich B Conze; Dragana Jankovic; Jonathan D Ashwell
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

Review 8.  Autophagy and NF-kappaB: fight for fate.

Authors:  Gutian Xiao
Journal:  Cytokine Growth Factor Rev       Date:  2007-05-07       Impact factor: 7.638

9.  Endotoxin-Induced IL-6 Promoter Activation in Skeletal Muscle Requires an NF-κB Site.

Authors:  David Yeagley; Charles H Lang
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2010-01-01

10.  PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation.

Authors:  Pengrong Yan; Jing Fu; Zhaoxia Qu; Shirong Li; Takashi Tanaka; Michael J Grusby; Gutian Xiao
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.